Table I. Participant characteristics
GenderRace/EthnicityPlasma VL, RNA Copies per mla (Median) (Range)CD4 Count, Cells per mm3 (Median) (Range)Time Post–HIV+ Diagnosis, y (Median) (Range)
C (n = 10)M, 5AA, 784471620.5
F, 3C, 2<40–1727353–25424–29.8
T, 2Mx, 1
V untreated (n = 15)M, 15AA, 720,5445062.75
C, 4393–186,307236–10751–22.67
HL, 3
Mx, 1
ART-Tx (n = 13)M, 11AA, 3<4060318
F, 1C, 7NA193–8112.7–27.1
T, 1HL, 3
SN (n = 10)bM, 10AA, 1NA950NA
C, 6NA600–1211NA
HL, 2
Mx, 1
  • a Median calculated using only detectable VL data points.

  • b CD4 count unavailable for one subject.

  • AA, African American; C, Caucasian; F, female; HL, Hispanic/Latino; M, male; Mx, mixed; NA, not applicable; T, transgender (M to F).